Pluristem Therapeutics Inc

NASDAQ:PSTI  
2.74
-0.25 (-8.36%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Pluristem Therapeutics Inc Stock, NASDAQ:PSTI

MATAM Advanced Technology Park, Building No. 5, Haifa, Haifa 3508409
United States of America
Phone: +972.74.710.7171
Number of Employees: 153

Description

Pluristem Therapeutics, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The firm focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.